RPH Stock Overview
Operates a chain of pharmacies in Romania. More details
| Snowflake Score | |
|---|---|
| Valuation | 2/6 |
| Future Growth | 0/6 |
| Past Performance | 1/6 |
| Financial Health | 6/6 |
| Dividends | 0/6 |
My Notes
Capture your thoughts, links and company narrative
S.C. Ropharma S.A. Competitors
Price History & Performance
| Historical stock prices | |
|---|---|
| Current Share Price | RON 0.17 |
| 52 Week High | RON 0.23 |
| 52 Week Low | RON 0.16 |
| Beta | 0.22 |
| 1 Month Change | -2.82% |
| 3 Month Change | 4.24% |
| 1 Year Change | -14.85% |
| 3 Year Change | -19.63% |
| 5 Year Change | -39.01% |
| Change since IPO | -61.78% |
Recent News & Updates
S.C. Ropharma (BVB:RPH) Is Experiencing Growth In Returns On Capital
Dec 06
Here's What's Concerning About S.C. Ropharma's (BVB:RPH) Returns On Capital
Dec 09S.C. Ropharma (BVB:RPH) Is Reinvesting At Lower Rates Of Return
Sep 23Recent updates
S.C. Ropharma (BVB:RPH) Is Experiencing Growth In Returns On Capital
Dec 06Here's What's Concerning About S.C. Ropharma's (BVB:RPH) Returns On Capital
Dec 09S.C. Ropharma (BVB:RPH) Is Reinvesting At Lower Rates Of Return
Sep 23Is S.C. Ropharma (BVB:RPH) Using Too Much Debt?
Jun 01Some Investors May Be Worried About S.C. Ropharma's (BVB:RPH) Returns On Capital
Mar 16S.C. Ropharma (BVB:RPH) Takes On Some Risk With Its Use Of Debt
May 15S.C. Ropharma (BVB:RPH) Might Be Having Difficulty Using Its Capital Effectively
Mar 26Should You Be Impressed By S.C. Ropharma's (BVB:RPH) Returns on Capital?
Dec 23
We Wouldn't Rely On S.C. Ropharma's (BVB:RPH) Statutory Earnings As A Guide
Nov 24Shareholder Returns
| RPH | RO Consumer Retailing | RO Market | |
|---|---|---|---|
| 7D | -2.3% | -1.6% | -1.6% |
| 1Y | -14.9% | -2.0% | 5.7% |
Return vs Industry: RPH underperformed the RO Consumer Retailing industry which returned -2% over the past year.
Return vs Market: RPH underperformed the RO Market which returned 5.7% over the past year.
Price Volatility
| RPH volatility | |
|---|---|
| RPH Average Weekly Movement | 5.6% |
| Consumer Retailing Industry Average Movement | 4.0% |
| Market Average Movement | 4.7% |
| 10% most volatile stocks in RO Market | 11.6% |
| 10% least volatile stocks in RO Market | 2.9% |
Stable Share Price: RPH has not had significant price volatility in the past 3 months compared to the RO market.
Volatility Over Time: RPH's weekly volatility (6%) has been stable over the past year.
About the Company
| Founded | Employees | CEO | Website |
|---|---|---|---|
| 1952 | 1,203 | Mihai Miron | www.ropharma.ro |
S.C. Ropharma S.A. operates a chain of pharmacies in Romania. The company distributes over-the-counter medications, food supplements, cosmetics, medical devices, dermato-cosmetics, para pharmaceuticals, and other medicines through pharmaceutical warehouses. It also offers cardio-vascular, dermatological, digestive, ophthalmological, osteo-articular, respiratory, urogenital, and diabetes medicines.
S.C. Ropharma S.A. Fundamentals Summary
| RPH fundamental statistics | |
|---|---|
| Market cap | RON 87.94m |
| Earnings (TTM) | RON 35.08k |
| Revenue (TTM) | RON 1.19b |
2,507x
P/E Ratio0.1x
P/S RatioIs RPH overvalued?
See Fair Value and valuation analysisEarnings & Revenue
| RPH income statement (TTM) | |
|---|---|
| Revenue | RON 1.19b |
| Cost of Revenue | RON 916.19m |
| Gross Profit | RON 270.69m |
| Other Expenses | RON 270.65m |
| Earnings | RON 35.08k |
Last Reported Earnings
Jun 30, 2024
Next Earnings Date
n/a
| Earnings per share (EPS) | 0.000069 |
| Gross Margin | 22.81% |
| Net Profit Margin | 0.003% |
| Debt/Equity Ratio | 26.9% |
How did RPH perform over the long term?
See historical performance and comparisonCompany Analysis and Financial Data Status
| Data | Last Updated (UTC time) |
|---|---|
| Company Analysis | 2024/12/24 14:17 |
| End of Day Share Price | 2024/12/23 00:00 |
| Earnings | 2024/06/30 |
| Annual Earnings | 2023/12/31 |
Data Sources
The data used in our company analysis is from S&P Global Market Intelligence LLC. The following data is used in our analysis model to generate this report. Data is normalised which can introduce a delay from the source being available.
| Package | Data | Timeframe | Example US Source * |
|---|---|---|---|
| Company Financials | 10 years |
| |
| Analyst Consensus Estimates | +3 years |
|
|
| Market Prices | 30 years |
| |
| Ownership | 10 years |
| |
| Management | 10 years |
| |
| Key Developments | 10 years |
|
* example for US securities, for non-US equivalent regulatory forms and sources are used.
Unless specified all financial data is based on a yearly period but updated quarterly. This is known as Trailing Twelve Month (TTM) or Last Twelve Month (LTM) Data. Learn more here.
Analysis Model and Snowflake
Details of the analysis model used to generate this report is available on our Github page, we also have guides on how to use our reports and tutorials on Youtube.
Learn about the world class team who designed and built the Simply Wall St analysis model.
Industry and Sector Metrics
Our industry and section metrics are calculated every 6 hours by Simply Wall St, details of our process are available on .
Analyst Sources
S.C. Ropharma S.A. is covered by 1 analysts. 0 of those analysts submitted the estimates of revenue or earnings used as inputs to our report. Analysts submissions are updated throughout the day.
| Analyst | Institution |
|---|---|
| Roxana Dascalu | SSIF IEBA Trust SA |